Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CORGENTECH INC | 5,799,841 | reported | 06 Jan 2010 | tx 11+2,236,936−2,651,899 |
| APPLIED GENETIC TECHNOLOGIES CORP | 2,828,755 | reported | 01 Apr 2014 | tx 5+2,984,400−99,006,493 |
| ZS Pharma, Inc. | 2,646,643 | reported | 08 Jun 2015 | tx 5−287,024 |
| Neothetics, Inc. | 2,137,763 | reported | 15 Dec 2015 | tx 3+36,390−529,261 |
| Allakos Inc. |
| 86,762 |
| reported |
| 25 May 2023 |
| tx 18+12,211,952−11,316,541 |
| Krystal Biotech, Inc. | 73,293 | reported | 27 Feb 2026 | tx 51+407,051−581,999 |
| PLC SYSTEMS INC | 60,579 | reported | 31 Dec 2018 | tx 24+6,643,723 |
| Esperion Therapeutics, Inc. | 23,449 | reported | 27 May 2021 | tx 26+2,812,342−2,780,504 |
| SUTRO BIOPHARMA, INC. | 11,610 | reported | 17 Jun 2019 | tx 10+1,982,544−50,736,989 |
| DYNAVAX TECHNOLOGIES CORP | 2,530 | reported | 14 Nov 2006 | tx 13+1,539,686−1,379,654 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Feb 2026 | SALE | Krystal Biotech, Inc. | 2,373 | 276.17 USD | |
| 27 Feb 2026 | SALE | Krystal Biotech, Inc. | 9,430 | 275.45 USD | |
| 24 Feb 2026 | SALE | Krystal Biotech, Inc. | 2,425 | 274.90 USD | |
| 24 Feb 2026 | SALE | Krystal Biotech, Inc. | 1,674 | 268.67 USD | |
| 24 Feb 2026 | SALE | Krystal Biotech, Inc. | 930 | 269.50 USD | |
| 24 Feb 2026 | SALE | Krystal Biotech, Inc. | 1,891 | 267.37 USD | |
| 24 Feb 2026 | SALE | Krystal Biotech, Inc. | 4,339 | 266.62 USD | |
| 24 Feb 2026 | SALE | Krystal Biotech, Inc. | 1,604 | 265.54 USD | |
| 24 Feb 2026 | SALE | Krystal Biotech, Inc. | 900 | 264.60 USD | |
| 24 Feb 2026 | SALE | Krystal Biotech, Inc. | 62 | 263.05 USD | |
| 24 Feb 2026 | SALE | Krystal Biotech, Inc. | 373 | 271.09 USD | |
| 24 Feb 2026 | SALE | Krystal Biotech, Inc. | 370 | 269.83 USD | |
| 26 Feb 2026 | SALE | Krystal Biotech, Inc. | 2,638 | 276.32 USD | |
| 26 Feb 2026 | SALE | Krystal Biotech, Inc. | 5,103 | 275.28 USD | |
| 25 Feb 2026 | SALE | Krystal Biotech, Inc. | 700 | 275.00 USD | |
| 24 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 37,895 | 2.46 USD | |
| 24 Feb 2026 | SALE | Krystal Biotech, Inc. | 569 | 262.91 USD | |
| 24 Feb 2026 | SALE | Krystal Biotech, Inc. | 1,733 | 264.12 USD | |
| 24 Feb 2026 | SALE | Krystal Biotech, Inc. | 3,557 | 265.08 USD | |
| 24 Feb 2026 | SALE | Krystal Biotech, Inc. | 8,986 | 266.18 USD | |
| 24 Feb 2026 | SALE | Krystal Biotech, Inc. | 11,673 | 266.97 USD | |
| 24 Feb 2026 | SALE | Krystal Biotech, Inc. | 6,671 | 268.04 USD | |
| 24 Feb 2026 | SALE | Krystal Biotech, Inc. | 3,963 | 268.97 USD | |
| 24 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 37,895 | 0.00 USD | deriv |
| 30 Jun 2025 | GRANT_AWARD | Krystal Biotech, Inc. | 5,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 21 Sept 2022.